4D Molecular Therapeutics's total assets for Q2 2025 were $473.64M, a decrease of -8.16% from the previous quarter. FDMT total liabilities were $52.75M for the fiscal quarter, a 14.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.